GlobalData's Medical Devices sector report, "Bare Metal
Stents (BMS) - Medical Devices Pipeline Assessment, 2016" provides an overview of Bare Metal
Stents (BMS) currently in pipeline stage.
Through its selection of EdgePresence, the company will be able to provide its services along with bare metal
colocation solutions for enterprise businesses in edge markets throughout the US EdgePresence solutions are highly scalable providing access to robust low latency network connectivity including transit and transport services from each EdgePod(TM) location.
"Using drug-eluting stents over bare metal
stents in these lesions is the appropriate thing to do."
With a disk-to-disk backup and disaster recovery solution, users can recover files in the time it takes to browse to them through Windows, and perform bare metal
recovery in the time it takes to copy a file from the network.
The inflammatory responses and biocompatibility observed with CV Therapeutics' technology in preclinical studies are similar to results seen with bare metal
Food and Drug Administration (FDA) in December 2006 warns that high-risk patients who receive drug-eluting stents may be more likely to suffer serious clots long after the stents were put in, compared to those with older and cheaper bare metal
Boston Scientific's analysis, based on data from 2,797 patients, differed from previous acknowledgements by the company of a small but statistically significant risk of thrombosis from Taxus compared to bare metal
Stents come in two forms: bare metal
, or coated with drugs designed to keep the arteries from re-clogging.
In year 1, initially the risk was lower in the group with drug-eluting stents than in the group with bare metal
Results from the Swedish study of nearly 48,000 patients now suggest the devices work as promised, especially in high-risk patients, who had a 74% lower risk of having a clogged stent compared with similar patients who got a bare metal
"Outcomes from prior registry and randomised trials of drug-eluting stents compared to bare metal
stents in heart attack patients have been conflicting.
The endothelial progenitor cell capture stent provides an excellent alternative to bare metal
stents for the treatment of these challenging lesions." The paper, titled "One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent," is based on a single-center, non-randomized study.